CPAP use may drive lower mortality in patients with IPF plus OSA vs. IPF only
SAN FRANCISCO — Fewer patients with idiopathic pulmonary fibrosis and obstructive sleep apnea died vs. patients with idiopathic pulmonary fibrosis alone, according to data presented at the American Thoracic Society International Conference.Reduced mortality in this population may be due to OSA treatment, according to researchers.